Partner Article
Northwich Veterinary pharmaceutical company report gross profit up 5%
Northwich based veterinary pharmaceutical business Dechra Pharmaceuticals PLC report gross profit is up 5% at £56.9 million.
The cheshire based company released its half yearly report today, reporting strong revenue growth however profits have been influenced by strong currency headwinds.
The company report that currency problems will continue to affect its financial performance throughout the year.
The group have continued its expansion plans opening in Italy in March 2014 and begining trading in Canada in January 2015.
Chief Executive Officer, Ian Page, said: “The Group has made a solid start to the year with continued momentum in Europe and a strong performance in the US.
“Our focus on executing our strategy is delivering value to shareholders.
“Our core portfolio demonstrates growth, our product pipeline is delivering results and our global expansion is progressing well.”
This was posted in Bdaily's Members' News section by Sophia Taha .
Global event supercharges North East screen sector
Is construction critical to Government growth plan?
Manufacturing needs context, not more software
Harnessing AI and delivering social value
Unlocking the North East’s collective potential
How specialist support can help your scale-up journey
The changing shape of the rental landscape
Developing local talent for a thriving Teesside
Engineering a future-ready talent pipeline
AI matters, but people matter more
How Merseyside firms can navigate US tariff shift
The importance of human insight in an AI world